B Lindelöf

3.3k total citations · 1 hit paper
53 papers, 2.3k citations indexed

About

B Lindelöf is a scholar working on Epidemiology, Dermatology and Oncology. According to data from OpenAlex, B Lindelöf has authored 53 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 18 papers in Dermatology and 13 papers in Oncology. Recurrent topics in B Lindelöf's work include Nonmelanoma Skin Cancer Studies (14 papers), Allergic Rhinitis and Sensitization (8 papers) and Polyomavirus and related diseases (7 papers). B Lindelöf is often cited by papers focused on Nonmelanoma Skin Cancer Studies (14 papers), Allergic Rhinitis and Sensitization (8 papers) and Polyomavirus and related diseases (7 papers). B Lindelöf collaborates with scholars based in Sweden, United Kingdom and France. B Lindelöf's co-authors include Bárður Sigurgeirsson, H Gäbel, Robert S. Stern, Johanna Adami, Anders Ekbom, Fredrik Granath, Karin M. Ekström, B Rydh, Bengt Glimelius and Hans‐Olov Adami and has published in prestigious journals such as The Lancet, British Journal of Cancer and Journal of Dental Research.

In The Last Decade

B Lindelöf

53 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer risk following organ transplantation: a nationwide cohort study in Sweden

2003 527 citations Johanna Adami, B Lindelöf et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B Lindelöf Sweden	21	982	970	803	366	363	53	2.3k
Marc D. Brown United States	26	983 1.0×	1.1k 1.2×	1.0k 1.3×	420 1.1×	411 1.1×	70	2.6k
Rafael Botella‐Estrada Spain	28	754 0.8×	1.0k 1.1×	1.0k 1.3×	213 0.6×	310 0.9×	187	2.3k
David Weedon Australia	29	1.4k 1.4×	1.0k 1.1×	1.2k 1.5×	388 1.1×	278 0.8×	129	3.3k
N.H. Cox United Kingdom	25	904 0.9×	816 0.8×	891 1.1×	525 1.4×	163 0.4×	74	2.4k
Agustı́n Alomar Spain	23	536 0.5×	343 0.4×	855 1.1×	232 0.6×	264 0.7×	109	1.8k
Hugh Morris Gloster United States	16	1.2k 1.2×	1.0k 1.0×	1.2k 1.5×	504 1.4×	124 0.3×	54	2.6k
C. Crosti Italy	29	1.4k 1.4×	524 0.5×	1.4k 1.7×	261 0.7×	277 0.8×	132	2.8k
Graham Colver United Kingdom	18	806 0.8×	372 0.4×	857 1.1×	218 0.6×	106 0.3×	56	1.5k
Jason K. Rivers Canada	28	650 0.7×	1.4k 1.4×	1.5k 1.8×	146 0.4×	189 0.5×	127	2.9k
Antonio Martorell Spain	29	756 0.8×	470 0.5×	1.7k 2.1×	836 2.3×	226 0.6×	175	2.7k

Countries citing papers authored by B Lindelöf

Since Specialization

Citations

This map shows the geographic impact of B Lindelöf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Lindelöf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Lindelöf more than expected).

Fields of papers citing papers by B Lindelöf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Lindelöf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Lindelöf. The network helps show where B Lindelöf may publish in the future.

Co-authorship network of co-authors of B Lindelöf

This figure shows the co-authorship network connecting the top 25 collaborators of B Lindelöf. A scholar is included among the top collaborators of B Lindelöf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Lindelöf. B Lindelöf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Lindelöf, B, Jan Lapins, & Henrik Dal. (2017). Shift in Occupational Risk for Basal Cell Carcinoma from Outdoor to Indoor Workers: A Large Population-based Case-control Register Study from Sweden. Acta Dermato Venereologica. 97(7). 830–833. 17 indexed citations

2.

Lohela-Karlsson, Malin, B Lindelöf, Carl‐Fredrik Wahlgren, K Wiklund, & Ylva Rodvall. (2015). Mobile Teledermatology is a Valid Method to Estimate Prevalence of Melanocytic Naevi in Children. Acta Dermato Venereologica. 95(3). 303–306. 12 indexed citations

3.

Fernberg, Pia, Gustaf Edgren, Johanna Adami, et al.. (2011). Time Trends in Risk and Risk Determinants of Non-Hodgkin Lymphoma in Solid Organ Transplant Recipients. American Journal of Transplantation. 11(11). 2472–2482. 37 indexed citations

4.

Lindelöf, B, et al.. (2008). Allergy and autoimmune disease: a registry‐based study. Clinical & Experimental Allergy. 39(1). 110–115. 11 indexed citations

5.

Lindelöf, B, Fredrik Granath, Maria Tengvall-Linder, & Anders Ekbom. (2005). Allergy and cancer. Allergy. 60(9). 1116–1120. 51 indexed citations

6.

Agnarsson, Bjarni A., et al.. (1994). Risk of lymphoma in patients with dermatitis herpetiformis. BMJ. 308(6920). 13–13. 68 indexed citations

7.

Baldursson, Baldur Tumi, Bárður Sigurgeirsson, & B Lindelöf. (1993). Leg ulcers and squamous cell carcinoma. An epidemiological study and a review of the literature.. Acta Dermato Venereologica. 73(3). 171–174. 42 indexed citations

8.

Lindelöf, B. (1991). Psoriasis and cancer.. Acta Dermato Venereologica. 71(1). 89–90. 1 indexed citations

9.

Lindelöf, B & Bárður Sigurgeirsson. (1991). PUVA treatment in Sweden.. PubMed. 169. 3–6. 8 indexed citations

10.

Lindelöf, B, B Forslind, Marita Hilliges, O Johansson, & Lennart Åström. (1991). Langerhans' cell histiocytosis in an adult.. Acta Dermato Venereologica. 71(2). 178–180. 3 indexed citations

11.

Lindelöf, B. (1991). PUVA and cancer: a large-scale epidemiological study. The Lancet. 338(8759). 91–93. 196 indexed citations

12.

Lindelöf, B, Gunnar Eklund, S. Lidén, & Robert S. Stern. (1990). The prevalence of malignant tumors in patients with psoriasis. Journal of the American Academy of Dermatology. 22(6). 1056–1060. 56 indexed citations

13.

Lindelöf, B. (1989). Psoriasis of the nails treated with grenz rays: a double-blind bilateral trial.. PubMed. 69(1). 80–2. 25 indexed citations

14.

Lindelöf, B, et al.. (1988). Human hair form. Morphology revealed by light and scanning electron microscopy and computer aided three-dimensional reconstruction.. PubMed. 124(9). 1359–63. 87 indexed citations

15.

Berg, M, et al.. (1988). Absence of mutagenic response to radiation from a video display terminal.. Scandinavian Journal of Work Environment & Health. 14(1). 49–51. 14 indexed citations

16.

Lindelöf, B & Magnus Lindberg. (1987). The effect of grenz rays on irritant skin reactions in man. Acta Dermato Venereologica. 67(2). 128–132. 4 indexed citations

17.

Lindelöf, B, Karin Wrangsjö, & S. Lidén. (1987). A double-blind study of Grenz ray therapy in chronic eczema of the hands. British Journal of Dermatology. 117(1). 77–80. 41 indexed citations

18.

Lindelöf, B, Anders Eklund, & S. Lidén. (1985). Kveim test reactivity in Melkersson-Rosenthal syndrome (cheilitis granulomatosa). Acta Dermato Venereologica. 65(5). 443–445. 11 indexed citations

19.

Johannesson, Anders & B Lindelöf. (1985). The effect of grenz rays on psoriasis lesions of the scalp: a double blind bilateral trial.. PubMed. 2(6). 388–91. 6 indexed citations

20.

Lindelöf, B, S. Lidén, & AM Ros. (1984). Effect of grenz rays on Langerhans´ cells in human epidermis. Acta Dermato Venereologica. 64(5). 436–438. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact